Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-12-19

Clinical Trial Update: TOLER-ENT Study: A Study to Investigate the Tolerance of the High Energy, High Protein Formula Sondalis® HP 2 kcal [NA]

View source ↗

Summary

The TOLER-ENT study evaluating the tolerance of the high energy, high protein formula Sondalis HP 2 kcal in malnutrition was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sondalis HP 2 kcal

Snippet

Sponsor: Société des Produits Nestlé (SPN) | Conditions: Malnutrition | NA | Status: TERMINATED